Form 4: Select Medical Director Receives Restricted Stock Grant

Select Medical Holdings Corp. director Parvinderjit S. Khanuja was granted 14,035 shares of restricted common stock, vesting on July 29, 2026.

Summary

• Director Parvinderjit S. Khanuja of Select Medical Holdings Corp. (SEM) was granted 14,035 shares of common stock.
• The transaction occurred on July 29, 2025, with an acquisition price of $0 per share, indicating a grant.
• These shares are restricted stock and are scheduled to vest in full on July 29, 2026, which is the first anniversary of the grant date, subject to certain exceptions.
• Following this transaction, the director beneficially owns a total of 79,124 shares of common stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is generally a positive sign, indicating alignment of interests and commitment. It's a routine compensation event, not a major market mover, hence a neutral-to-positive score.

Positives

• Grant of restricted stock aligns the director's interests with long-term shareholder value.
• The director's increased equity stake demonstrates continued commitment to the company.

Risks

• The vesting of the restricted stock is subject to certain unspecified exceptions, which could impact the director's ultimate ownership.

Future Outlook

The restricted stock grant is set to vest on July 29, 2026, indicating a future milestone for the director's equity compensation.

Industry Context

This transaction is a standard form of executive and director compensation in the healthcare services industry, aiming to align leadership incentives with company performance and long-term shareholder interests.

Corporate Governance

Related Party Transactions

• The grant of 14,035 shares of restricted stock to Director Parvinderjit S. Khanuja constitutes a related party transaction, as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders by tying compensation to future stock performance and retention.

Next Steps

• The 14,035 shares of restricted stock are expected to vest on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine restricted stock grant to a director, which is a common compensation practice aimed at aligning management interests with shareholder value. It does not contain information that would fundamentally alter the investment thesis for Select Medical Holdings Corp., nor does it suggest any significant positive or negative catalysts. Therefore, a 'hold' recommendation is appropriate as it provides no new information to warrant a change in existing positions.

Keywords

Select Medical Holdings Corp, SEM, Form 4, Restricted Stock, Equity Grant, Director Compensation, Insider Ownership, Stock Vesting, Corporate Governance